Chronic Rhinosinusitis Trial, Recruiting NCT07299474 Sponsor: Cedars-Sinai Medical Center Condition: Chronic Rhinosinusitis
Back to Chronic Rhinosinusitis

Chronic Rhinosinusitis Trial, Recruiting

NCT07299474
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are having an ear, nose, or throat procedure done while awake at an outpatient clinic
  • People who are able to understand and agree to take part in the study by giving their consent

Who may not be able to join:

  • People who have an allergy or sensitivity to fragrances or scents
  • People who have taken anti-inflammatory or other pain-relieving medicines (such as ibuprofen or similar drugs) within the past 48 hours
  • People who regularly take medicines for anxiety, sleep, allergies (the kind that cause drowsiness), or depression, and have taken them within the past 4 weeks
  • People who are currently pregnant or breastfeeding
  • People who have taken part in another clinical research study within the past 30 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ankona Ghosh, MD, Cedars-Sinai Medical Center

Phone: 310-560-7331

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cedars-Sinai Medical Center
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in visual analog scale anxiety, measured on a 10 cm scale; Likert scale of pain, measured on a scale of 0-10; Likert scale subjective improvement with pain, measured on scale of 1-5

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov